30
Participants
Start Date
January 1, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
docetaxel, anthracycline, cyclophosphamide
"1. Participants were required to receive 6 cycles of TEC/TAC neoadjuvant chemotherapy, and radical mastectomy was required after chemotherapy.~2. 5ml peripheral venous blood was collected before chemotherapy, after 2 cycles of chemotherapy, before surgery, and six months after surgery.~3. Clinicopathological data, chemotherapy-related adverse events and prognostic information of patients should be collected during the study."
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER